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Available data concerning the non· hepatic sourc" '"If plasma factor VIII are conflicting. 
In the present study, dogs with factor VIII deflciery hemophilia were transplanted 
with spleen or vascularized lymph node grafts obtained from norma I donor dogs. 
Postoperative immunosuppression was done with azathioprine and heterologous 
antilymphocyte globulin. Four spleen transplants were successful and the recipients 
had positive technetium sulfide spleen scans along with adequate plasma factor VIII 
levels for three to eight weeks. Cessation of graft isotope uptake was accompanied 
by prompt disappearance of plasma factor in all four dogs. Histologically, the 
grafts were rejected at this time. In one dog, a second spleen graft immediately 
restored therapeutic factor VIII levels. Four lymph node transplants were successful 
and plasma factor VIII was detected for one, one, two, and ten weeks. Three dogs 
rejected their lymph node grafts with disappearance of factor VIII, while one had 
a viable transplant removed with loss of factor VIII within twa days. The data 
suggest that factor VIII is produced in the lymphatic tissue of the dog. 
From the Den/'er Veterans Administration Hospital, the Departments of Surgery and 
Pediatrics, L'niC'eT5ary of Culorado School of Aledicine, Denver, Colo., and the Department 
of Pathology, St. jJary's Hospital and .Hedical School, London. England 
D A TAP R 0 \' IDE D by recent experiments 
with organ transplantation10. 11. 19 has indi-
cated a multiorgan site of synthesis of plasma 
"II~ntihemophilic factor (factor VIII). Thus, 
'f\' a major role of hepatic tissue in the process 
"''''as established by the finding that transplan-
tation of a normal liYer into a hemophilic 
dog raised plasma factor VIII to an essen-
tially normal leye\. But in the same studies, 
eyidence of production of the antihemophilic 
factor in other organs "as adduced by the 
obsen;ation that replacement of the liver in 
The \\'ork was supported by research grants from the 
DI'!\\'t'r Vt'tt'rans ;\dministration: by ~rants Af-A~f-MUB9U 
and A~f-nTii:? from the :\ational Institutes of Health: 
and bv "ran,s RR-1I0051 and RR-00069 from the General 
Clinical Research Centers Prog-ram of the Division of 
oe~tDal ell Rt':-.ourcl'<'; .. '\'ational I nstitlltes of Hl'alth. 
\c('t'ptt"d for publiclCioll :\farch 1'2. E)7{. 
J·ol. 75, No.5, pp. i25-733 
a normal dog with a hemophilic organ led 
to only a temporary decrease in plasma fac-
tor sff~yDailable data concerning the non-
hepatic source of the factor are conflicting. 
One group of im'estigators reported correc-
tion of hemophilia following splenic trans-
plantation in dogs,lI· 1, but this finding could 
not be reproduced by others. 10- 12 . 1" In other 
canine experiments. transplantation of the 
kidnev and the bone marrow wcre found not 
to cause detectable changes in the antihemo-
f~C factor. 10, lD 
l2',n the present stud:-, canine hemophilic 
recipients of splenic or vascularized hmph 
node grafts were both found to maintain sig-
nificant levels of plasma factor VIII. This 
result. in conjunction with the prc\'ious find-
ll1gs. indicates that canine antihemophilic 
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Fig. 1. Technique of vascularized lymph node transplantation. A, The root of the mesentery 
is dissected free from the small bowel in the donor, preserving the mesenteric vessels. B, The 
graft has been revascularized in the neck of the recipient. Vascular anastomoses are to the 
carotid artery and external jugular vein. The graft is placed in a subcutaneous pocket. 
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Fig. 2. Effect of plasma infusion on plasma factor 
VII I in three hemophilic dogs. In all instances, 
factor VIII returned to near zero in three days. 
One of the dogs received the immunosuppressive 
regimen used in the graft recipients but the effect 
ui plasma infusion was not thereby prolonged. 
bctor is produced in tissues common to the 
li\'er. spleen. and h-mph noda 
METHODS 
Elen'n Labrador dogs \\'ith factor Vln 
deficiency hemophilia (four females and 
seyen males. age 15 to 20 months. weighing 
12 to 22 kilograms) were used. * All but two 
had had bleeding complications which 
ranged from simple surface hematomas to 
hemarthroses that had resulted in crippling 
arthritis. With blood drawing, the venipunc-
ture site required prolom;ed compressIOn. 
During observation in our laboratory for 
three to six months. plasma factor VIII was 
less than one percent when assayed on numer-
ous occasIOns. Health\'. nonnal Labrador 
dogs served as graft donors: the animals \\'pre' 
heparinized just prior to graft removal. The 
anesthetic ag-ent was sodium pentobarbital 
supplemented \\ith phencyclidine hydrochlo-
ride. 
"'hole org-an splenic transplantation \\as 
achieved with \ascular anastomoses to the 
*The dogs were from the hemophilic colony developed by 
Dr. H. G. Downil' of the Ontario Veterinary Colle~eK 
rniver~ity of Guelph. Guelph. Ontario, by b[eedin~ 
\\ hich bED~an in 19:;6. These do~s are not [e lated to 
factor VIII-deficient do~s elsewhere in th ... Cnited States 
or Canada. Pedil;'n et's pro .... ided by Dr. F. Locz of the 
Guelph Biomedical Science Depanml'nt indicatl' a pattern 
or s('x-linked inheritance identical to that ~ecn in human 
classical hcmophilia. The male do~s \\"('fC hcmizDv~ous: 
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Fig. 3. Postoperative technetium disulfide scan in a splenic reCipIent (Dog' No, 2), A, Eight 
days after transplantation. The graft which is visualized in the left lower abdomen shows an 
excellent uptake, The lower edge of the liver is also seen, The animal's own spleen was 
removed. Band C, Seventeen and 19 days after transplantation the uptake is decreasing 
rapidly. On day 21 the graft could no longer be visualized radiographically, 
recipient iliac \'essels as described previouslv." 
Ischemia time for the grafts \\'as 23 to :10 
minutes. The recipient spleen \\as removed. 
Postoperati\'ely, splenic graft function was 
assessed twice weekly by 99~f-technetium sul-
fide radioisotope scans, 
Lymph node grafts were prepared from 
the root of the mesentery of the small boweL 
preserving the superior mesenteric artery and 
\'ein (Fig. 1), In such a preparation. there 
are regularly two clusters of nodes. each 
having a size of approximately 1 bv 1 by 3 cm. 
Revascularization in the recipient \\'as done 
with end-to-end anastomosis of the mesen-
teric vessels to the carotid artery and ex-
ternal jugular vein. The graft was placed in 
a subcutaneous pocket in the neck (Fig. 1). 
Ischemia time \\as 21 to 33 minutes. 
Prior to operation. each recipient dog was 
transfused with 25 m!. per kilogram of fresh, 
normal dog plasma. To prevent or reduce 
allerg-y-Iike transfusion reactions, intra\'enous 
hvdrocortisR~~~~DD"D ~?l" .. ~K?~Ktg;y~I:" fB:~;~ I~!:1gygI::KKII~ 
I}~~~uDIimostoperatlve Immunosuppression K~ 
,,'as achieved with a two-drug regimen, 
Azathioprine. 1 to 8 mg-. per kilogram per \. 
day. was given orally; the daily dose was 
adjusted 'according to the peripheral white 
blood cell count. Horse antilvmphocvte g-lob- ~ 
ulin (ALG i (leukoagglutinin titer 1: 4-000, 
('\totoxic ,', er 1: 2561. 10 mg. per kilogram 
per dosf'. ,IS g-iven subcutaneously daily for 
\ the first two postoperative weeks. The ALG 
was produced as described for the human 
material at our institution:' except that 
canine thymic lymphocytes were used for the 
immunization. 
D·DraCDiorD~rfr·i~·Dat;;t;dD····pi;~~~ sampf~~D" 
was measured by the thromboplastin genera-
tion time assay of Pool and Robinson15 ; the 
normal reference plasma (100 percent activ-
ity) was pooled normal dog plasma. Cnlike 
one,stage assays for factor VIII (partial 
thromboplastin time assays), this method is 
relatively insensiti\'e to activated coagulation 
factors or traces of tissue thromboplastin or 
thrombin. 1 :! Assays for fibrinogen and factors 
II. V. and VII .,. X were done as previously 
described'; with the use of pooled normal dog 
plasma as the normal standard. The whole 
blood clotting time, prothrombin time, 
thrombin time. euglobulin lysis time. platelet 
count. hematocrit, and total white cell count 
Wf're performed by standard methods. 
TIiopsy and autopsy specimens from the 
grafts \\'t're stained with hematoxylin and 
eosin, methyl green pyronin, silver for retic-
ulin, Weigert's for elastic, and periodic 
acid-Schiff reagent, and then they were ex-
amined by light microscopy. 
RESULTS 
Effect of plasma infusion and immuno-
suppression only. Infusion of fresh clI1ine 
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Fig. 4. Plasma factor VIII in four hemophilic dogs that received whole organ splenic grafts. 
The solid line denotes that there was isotope uptake on the splenic scan. The dotted line 
indicates that isotope uptake was no longer recorded. Horizontal lines mark the 20 percent 
level. 
plasma, 25 Ill!. per kilogram. to three hemo-
philic dogs not undergoing concomitant 
transplantation caused a prompt rise in fac-
tor VIII. ~faximum values recorded after 
transfusion were 40, 50, and 125 percent 
in the three dogs, respectively. Three days 
b teT the factor had returned to near zero 
in all instances (Fic;. 2). One of the dogs 
was gi\'en the immunosuppressi\'e regimen 
used in the graft recipients. starting at the 
day of transfusion. There was no apparent 
effect on the plasma factor VIII. The two 
other dogs were used as graft recipients six 
to eight weeks later. 
Splenic transplantation. There were four 
hemophilic recipients of splenic transplants: 
:le of the' dogs received two consecutive 
rafts. Radioisotope scanning showed uptake 
in the grafts from the dav of transplantation 
to day 28. 19. 32. and 50 after operation. 
respecti\ely. During the last several days 
before disappearance of uptake, there was 
a gradual decline in the density of the radi-
ological picture (Fig. 3). The dog (Xo. 4) 
in which the graft picture disappeared after 
50 days, underwent retransplantation six 
days later. The second graft showed excel-
lent isotope uptake. but the dog died nine 
days postoperati\'elv with pneumonia. 
On the day of transplantation. plasma 
factor VIII in the four donor dogs was 100. 
40, 100, and 105 percent. respectiveh-. In 
the recipients. preoperative antihemophilic 
factor was less than one percent in all in-
stances. Postoperativelv, an initial peak. 
caused by plasma infusion. ,,'as followed by 
a few days of wide fluctuations I Fig. +'. 
Following this. the plasma factor VIII was 
essentially normal during three to four weeks 
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Fig". 5. Plasma factor VIII in four hemophilic dogs that recovered after receipt of a 
\"'Lularized lymph node graft. Horizontal lines mark the 20 percent leveL 
two (:\ns, 3 and 4) the level stabilized 
around 20 to -+0 percent for four and eight 
\\eeks. respectivelv. There were no clinical 
clottin~ problpms during or after surgen' ex-
('cpt that one dog (.:\0.4) had a brief period 
of woulld bleeding 12 days after transplanta-
tion :11 a time when the factor \\'as near 
/('[0. At the cessation of graft isotope uptake 
the plasma antihemophilic factor disap-
peared in all four dogs (Fig. 4). In the re-
t ransplall ted dog. the provision of a second 
C;Taft was again followed by a significant 
plasma level of factor VIII (Fig. +\. 
On assa\' one \\'pek after transplantation, 
the prnioush- prolonged dotting time was 
,}lOrterH'd to near normal. Several other clot-
ting parameters studied were unaffected. 
The hematocrit and white blood cell count 
I "·Be. had dropped moderately (Table I). 
The four original splenic grafts were re-
Illo\'ed three to seven days after the cessation 
fli their isotope uptake. Histologically, they 
showed end-stage rejection. There was ne-
crosis of most of the lymphocytes in the 
white pulp: on I\' a few large lymphoid cells 
with pyroninophilic cytoplasm sun'ived im-
mediately adjacent to the penicillarv arteri-
oles. The red pulp was necrotic and hem-
orrhagic, and there was fibrinoid necrosis of 
the walls of most of the arteries and arteri-
oles. 
At recipient df'ath. nine days aft" retrans-
plantation, the second graft of one dog (.:\0. 
4) showed a normal white pulp with abun-
dant germinal centers. and a red pulp that 
was congested and filled with mononuclear 
cells possessing pvroninophilic cytoplasm. 
The arteries and arterioles were normaL 
Lymph node transplantation. Six hemo-
philic dogs received vascularized lymph 
node grafts. In one dog. a severely con![estE'd 
graft was removed four days after transplan-
tation: there was thrombosis at the \'enous 
anastomosis. Another recipient that had 
730 Groth et ai. purK~ery 
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Table 1. Hematological findings before and one «uk after splenic or lymph node 
transplantation (mean ± S.E. in the groups)* 
Splenic transplantation 
Before After 
Whole blood clotting 
time (min.) 38 ± 10 13 :': 8 
Prothrombin time (sec. ) 7.5 ± 0.3 fl.l :': 0.3 
Thrombin time (sec. ) 9.1 :': 0.1 9.2 :': 0.:, 
Fibrinogen (mg./IOO 
mI.) 571 ± 50 524 :': 23 
Factor II (%) 95 ± 18 93 :': 5 
Factor V (%) 125 ± 15 97 ± 3 
Factor VII (%) 120 :!: 19 III :': 11 
Platelets (1000/mm.') 2+8 ± 75 198 ± 10 
Euglobulin lysis time 
(min.) 122 :!: 15 58 :!: 13 
Hematocrit (o/r: ) +1 :!: :: 29 :!: 3 
White blood reI I count 
(100/mm.') :lUI :!: 3.0 14.0 :!: :17 
*Factor VIII depicted in ci~sK 4 and 5. 
operations on the first and second postopera-
tive day because of bleeding from the graft 
site did not recover from anesthesia after the 
latter procedure. The other four dogs had 
an uneventful early postoperative course. 
Only these latter dogs will be discussed 
further. 
On the dav of transplantation. plasma 
factor VIn in the donor dogs used in the 
four technicallv successful ·experiments was 
62. 100, 110, and 102 percent, respectively. 
Prior to transplantation. the antihemophilic 
factor was less than one percent in all recipi-
ent dogs. After operation, an initial peak 
cal·i by the plasma infusion was followed 
by lecline to levels around five percent ex-
cept in one dog E~oK 5) in which the level 
dropped to zero for several days (Fig. 5). 
At this time, there was a transient bleeding 
diathesis in this dog. Subsequenth·. factor 
YIII levels rose in every animal and then 
fluctuated between 10 and 40 percent. In 
one dog (No.5), the graft was surgicallv 
removed 21 days after transplantation: in 
the next few days. the factor declined to 
less than one percent. In the other three 
dogs. the factor level was maintained be-
tween 10 and +0 percent for one. two. and 
t('11 \\'eeks, respectively (Fig. 5) . 
There was a significant shortening in the 
previously prolonged clotting time on assay 
Lymph node transplantatwn I 
Before After.v ormai ran{!e 
77 :!: 25 24 :!: + :i--l0 
7.8 :!: 0.2 8.2 :!: 0.3 6-7 
9.0 ± 0.4 9.6 :!: D.S 7-9 
604 ± 31 554 :!: 46 400-60f) 
93 ± 11 87 ± 7 70-100 
115 ± 5 118 ± 2 70- lflO 
88 ± 15 85 ± 13 70-150 
218 :!: 44 194 :': 80 200-400 
123 :': 17 104 ± 33 90-300 
+2 ± 3 33 ± 2 
22.4- :!: :u 14.1 :!: 3.4 
one week after transplantation. The findin!{s 
in other clotting parameters and in hemato-
crit and WBe were similar to those found 
in the spleen transplant group (Table 1\. 
Graft tissue was obtained on two different 
occasions when the recipient had circulating 
factor VIII; it was obtained in one dog \ :\'0. 
6) by an open biopsy performed ten da\s 
after transplantation and in another \:\'0. 
5) when the whole graft was deliberatelv 
removed on the twenty-first postoperati> 
day. Histologically. rejection was not ap-
parent in the 10 day graft, which showed a 
normal cortex with many germinal centers 
and a normal paracortical zone and 
medulla. In the 21 day graft. rejection was 
occurring. The cortex contained fewer 
Iymphocvtes than normal and onlv oc-
casional germinal centers. and there were a 
few focal areas of hemorrhagic necrosis. ThE' 
paracortical zone was expanded and filled 
with a mass of lymphoid cells, many of 
them large and with pyroninophilic C\to-
plasm. Mitoses were frequent in this zone. 
The medulla contained many plasma cells. 
Three lymph node transplants were ex-
amined three to seven days after plasma 
antihemophilic factor had returned to less 
than one percent. In one instance. the tissue 
became available at animal death 19 days 
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trrafts were surgicalh- remm·ed .. \ll sho\led 
marked rejection. In the two surg-ical speci-
mens, the cortex \vas depleted of all 
lymphocytes, there \\ere a few groups of 
large lymphoid cells with pyroninophilic 
cytoplasm in the paracortical zone. and the 
medulla contained some plasma cells. In the 
autopsy specimen. rejection \\as less ad-
\'anced and small areas remained in which 
there were some cortical lymphoid cells. a 
prolllinent paracortical zone of pyroninophil-
ic lymphoid cells, and abundant plasma 
cells in the medulla. In the two surgical 
specimens. the reticular cells survived and 
\vere the main cells in the cortex. 
DISCUSSION 
In 1967. \ \. ebster and colleagues 1S first 
reported on transplantation of the spleen in 
the hemophilic dog. Their animals were bred 
at the Cni\'ersity of North Carolina. Chapel 
Hill. X. C. In this pioneer stud\'. t\\·o re-
cipient animals were found to have im-
proved hemostasis and clotting tests for 
S2 and 72 hours after transplantation. More 
recently. the same investigators reported no 
sustained beneficial effect when studying 
similarly transplanted animals for weeks and 
months after operation. 1" They concluded 
that the role of the spleen is limited to the 
release of stored factor VI II as opposed to 
synthesis. Similar results were obtained by 
.\IcKee and associates12 and .\!archioro and 
associates lU• 11: both groups worked with 
dogs from the hemophilic beagle colony at 
Oklahoma State l..'niversit\'. Stillwater, 
Okla. In .\IcKee's series. 1 " two spleen trans-
plant recipients survived for seven and eight 
months. respecti\'ely: they displayed no post-
operative rise in plasma factor VIII despite 
continuous and excellent isotope uptake by 
their grafts . .\Iarchioro's group" reported on 
one dog in which the splenic graft remained 
\'iable as confirmed by biopsy for 93 days but 
with plasma antihemophilic factor levels 
ne\'er exceeding six percent. 
In contrast to the findings of these in-
vestigators. Xonnan and associates l' and Sise 
and co-workers" recorded significant levels 
of factor YIII in hemophilic canine re-
Clplents of splenic transplants which were 
also from the Oklahoma colony. This favor-
able finding was recorded in each of seven 
dogs and for a maximum length of 47 days 
after operation. L" nfortunately, the use of 
normal human plasma as a reference in the 
factor VIII assay precluded a truIv quan-
titative assessment of the degree of correc-
tion achieved in these experiments. 
In the present study, therapeutic levels 
(exceeding 20 percent) of antihemophilic 
factor developed for at least three \\eeks in 
all recipients of splenic grafts. with the 
longest period being eight weeks. A close 
correlation between graft function and 
plasma factor YIII was indicated by the 
concomitant disappearance of radioisotope 
uptake in the graft and of the antihemophil-
ic factor. 
The reason for the discrepant findings 
with splenic transplantation in the hemo-
philic dog reported by difTerent groups is 
obscure. The dogs used in the present study 
were from a different colony than those of 
the other investigators, but the sex-linked 
recessive pattern of our Guelph animals was 
the same. In our series, immunosuppression 
consisted of azathioprine in combination with 
antilymphocyte globulin while all earlier in-
\'Cstigators used azathioprine and prednisone, 
but it seems unlike I\' that this difference af-
fected the hematologic results. 
The finding in the present study that the 
provision of a vascularized lymph node 
graft, as well as a splenic graft. was ac-
companied by a sustained increase in plasma 
factor VIII IS evidence that lympho-
reticuloendothelial tissue produces the fac-
tor. The initial lack of plasma anti-
hemophilic factor in the lymph node re-
cipients could be a reflection of a smaller 
storage capacity in this graft. 
In 1971 Bouhasin and collaborators2 re-
ported a rise in plasma factor VIII in a 
hemophilic child that developed l~mpho­
blastic leukemia and postulated a role of the 
lymphocyte in antihemophilic globulin pro-
duction. Recent investigations1., indic;J.te 
that factor VIII antigen can be localized to 
endothelial cells of blood vessels in mal1\' 
in (;'(1111 I.'t Ill. 
EFr~ans including h"lllph nodes and spleen. 
The h-mphocvtl> could not be shown to haw 
factor \' I II antigens to any significant de-
gree in these studies. In light of these !lew 
findings and the past publications. a unify-
inQ," position might be that the deg-ree of 
hematolog-ic correction is proportional to the 
:lmount of tissue and/or blood \"('5s('ls in 
grafts \1 hether the grafts are primarih' 
l~Dmphatic (spleen, nodes) or not (lin'r). If 
this \Icre tnI('. it would not be surprisin~ 
that the liver. spleen. and lymph node grafts 
were corrective in that order of eA·ectiveness. 
Also. the finding of supernormal le\'els of 
fador VI II concomitant with very low le\'els 
of all other coagulation factors in a splen-
ectomized liver transplant recipient with a 
failing' graft indicates a site of synthesis of 
antihemophilic betor outside the !i\'er and 
spl('e!l." 
Of particular importance to our studies 
is the observations of Rickles and associates"; 
that the prolonged clotting time of factor 
VI II-deficient plasma can be corrected bv 
a lymphocyte procoag-ulant material charac-
terized as tissue factor and not factor VIII. 
These authors used a partial thromboplastin 
. time (PTT) test to demonstrate their find-
ings. Our factor VI II assays \Iere all done 
bv a thromboplastin g-e~eration time test 
(two-stage). Studies in our laboratory. which 
are being prepared publication. indicate 
that the two-stage )r VIII assay is not 
altered by the presence of thrombin or tis-
sue factor and, therefore. probably measures 
factor VII I clotting activity specifically. In 
rontrast. the PTT tvpe VIII assay is ex-
tremel\" sensitil'e to small amounts of tissue 
thromboplastin. These technical considera-
tions must be noted in determination of fac-
tor VI II activity after tissue transplantation. 
The results of the present stud\' keep open 
the question of feasibility of tissue trans-
plantation in patients with severe hemo-
philia. Previous attempts at splenic trans-
plantation for various disease entities in man 
have all resulted in graft rejection within 
months." ~K " and the single attempt at trans-
plantation for hemophilia was followed by 
graft rupture in seven days. ~ .\;onetheless, 
SUTl!.erv 
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the imprO\'ements 111 management intro-
duced into the field of transplantation owr 
the last few years may warrant a tri:d in 
carefully selected cases. 
REFERENCES 
1. Bloom, :\. L., Giddings, ]. C., and Wilks, 
C. J: Factor VIII on the vascular intima: 
Po>siblc importance in hemostasis and th rom-
bosis, :\'at. -"'cw Bioi. 241: 217. 1973. 
,) Bouhasin, j. D., Monteleone: P., and Altay, 
C.: Role of the lymphocyte in anti-
hemophilic globulin production: A rise in 
antihemophilic globulin levels in a hemophilic 
subject with acute leukemia. J. Lab. Clin. 
Med. 78: 122, 1971. 
3. Groth. C. G., Pechet, L., and StarzL T. E.: 
Coag-ulation during and after orthotopic 
transplantation of the h,_ an li\'cr, Arch. 
Surg. 98: 31, 1968. 
-t. Groth, C. G., lIagenfeldt, L., Dreborg-, S .. 
Lofstrom, B., Ockerman. P. A., Samuelsson, 
K., S\·ennerholm. L., Werner, B .. and West· 
berg, G.: Splenic transplantation in a cJ.se of 
Gaucher's disease, Lancet 1: 1260, 19 i 1. 
5. Groth, C. G., Kashiwagi, N., ~fooreI G. E., 
Husberg, B .. Bjorkt~nI C, Putnam, C. W .• 
and Starzl, T. E.: Production of a standard-
ized antilymphocyte globulin, in Seiler, F. R. 
and Schwick, H. G., editors: Behring Insti-
tute Mitteilungen (Behring Institute Work-
shop, Bad Soden [Ts] , April 23-25, 1972), 
Marburg, 1972, Behringwerke AG, Xo. 51. 
pp. 86-89. 
6. HJ.thaway, W. E., Belhasen. L. P.. and 
Hathaway, H. S.: Evidence for a new plasma 
thromboplastin factor. I. Case report, coagu-
lation studies, and physiochemical properties. 
Blood 26: 521,1965. 
7. Hathaway, W. E., Mull, M. M., Githens, J 
G., Groth, C. C., Marchioro, T. L., and 
Starzl, T. E.: Attempted spleen transplant in 
classical hemophilia, Transplantation 7: 73, 
1969. 
8. Hoyer, L. W., de los Santos. R. P., and 
Hoyer. J R.: Antihemophilic factor antigen: 
Localization in endothelial cells bv immuno-
fluorescent microscopy, J. Clin. Invest. 5?' 
2737, 1973. 
9. Marchioro, T. L., Rowlands, D. T., Jr .. 
Rifkind, D., Waddell, W. R .. StarzL T. E .• 
and Fudenberg, H.: Splenic homotransplanta-
tion, Ann. N. Y. Acad. Sci. 120: 626, 196+. 
10. Marchioro, T. L., Hougie, C .. Rae:de, H .. 
Epstein, R. B., and Thomas, E. D.: Hemo-
philia: Role of organ homografts. Science 
163: 188. 1969. 
11. Marchioro, T. L., Hougie, c., Ra!!de. H .. 












A rise in 
l hemophilic 
Lab. Clin. 
·:trzl, T .. E.: 
orthotopic 
'i"er, Arch. 
)reborg, S .. 
Samuelsson. 
and West-
:n a case of 
,J. 1971. 
lore, G. E., 
1m. C. W .. 
a standard-










r. 1., and 
'ansplant in 
:ion 7: 73, 




). T., Jr., 










Correction of coa~lllatioql In hemophilic riO!; i33 
,(rafts for hemophilia, Transplant. Proc. 1: 
316. 1969. 
12. McKee, P. :\., Cuussons, R. T., Buckner, 
R. G., Williams, G. R., and Hampton, J. W.: 
Effects of the spleen on canine factor VIII 
levels, J. Lab. Clin. Med. 75: 391, 1970. 
13. Niemetz, ]., and Nossel, H. L.: Activated 
coagulation factors: in vivo and in vitro 
studies, Br. ]. Haematol. 16: 37. 1969. 
H. ,,"orman. ]. C., Covelli, V. II., and Sise, H. 
S.: Transplantation of the spleen: Experi-
mental cure of hemophilia, Sl.'RGERY 64: I, 
1968. 
15. Pool, J. G., and Robinson, J.: Assay of 
plasma antihaemophilic globulin (AHG), Br. 
J. Haematol. 5: 17, 1959. 
16. Rickles. F. R., Hardin. J. A., Pittick. F. A., 
Hoyer, L. W., and Conrad, M. D.: Tissue 
factor acti,'ity in lymphocyte cultures from 
normal individuals and patients with hemo-
philia, Am_ ]. Clin. Invest. 52: 1427, 1973. 
17. Sise, H. ]., Joison, ]., Pegg, C. :\. S., and 
~ormanI ]. C.: Potential of the transplanted 
spleen in canine hemophilia, in Brinkhous. 
K. M., editor: Hemophilia and new hemor-
rhagic states. Chapel Hill. ~K C.. 1970. 
University of :".'orth Carolina Press, p. 106, 
18. Webster, W. P., Penick, G. D., Peacock. E. E., 
and Brinkhous. K. M.: Allotransplantation of 
spleen in hemophilia, N. C. ~ledK ]. 28: SOS, 
1967. 
19. Webster, W. P., Zukoski, C. F., Hutchin, P., 
Reddick, R. L., Mandel, S. R., and Penick. 
G. D.: Plasma factor VIII synthesis and 
control as revealed by canine organ trans-
plantation, Am. ]. Physiol. 220: 11+7, 1971. 
